8.500
−5,56%
2026-10-13
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +61.1% | +64.1% | 3 / 3 | +43.1% | -0.25 pp | +0.06 pp | +16.1% | 0.79 | 4.36 | 1.524 | +43,1% | 8,5 | +61,1% | 4.36 | 9.20 | −52,6% |
| Pts | 12 | 12 | 12 | 12 | 4 | 8 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 8.500 (close price on 2026-10-13)EPS (TTM): 1.949
Financial charts
1.Revenue & growth
VND bn1.524Q2/26
1.Revenue & growth
VND bn1.524Q2/26
2.Profit & growth
VND bn8,53Q2/26
3.Profit mix (Penman)
VND bn36,4Q2/26
4.Margins & cost structure
%5.2%Q2/26
5.Returns & cash cycle
% · days8.3%Q2/26
6.Earnings quality & cash
VND bn20,7Q2/26
7.Asset structure
VND bn845Q2/26
8.Funding & debt health
VND bn · times845Q2/26
9.Revenue backlog
VND bn6,27Q2/26
10.Valuation
times · %4,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %569Q2/26
Adjusted EPS growth, latest quarter
61.1%
Average adjusted EPS growth, 3 quarters
64.1%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26